These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients. Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715 [TBL] [Abstract][Full Text] [Related]
26. Dabigatran, bleeding, and the regulators. Moore TJ; Cohen MR; Mattison DR BMJ; 2014 Jul; 349():g4517. PubMed ID: 25056265 [No Abstract] [Full Text] [Related]
27. Place of dabigatran in contemporary pharmacotherapy. Gums JG Pharmacotherapy; 2011 Apr; 31(4):335-7. PubMed ID: 21449622 [No Abstract] [Full Text] [Related]
28. Direct thrombin inhibitors for the treatment of venous thromboembolism: analysis of the Dabigatran versus Warfarin clinical trial. Liem TK; Deloughery TG Semin Vasc Surg; 2011 Sep; 24(3):157-61. PubMed ID: 22153026 [TBL] [Abstract][Full Text] [Related]
32. The trouble with dabigatran. Charlton B; Redberg R BMJ; 2014 Jul; 349():g4681. PubMed ID: 25055830 [No Abstract] [Full Text] [Related]
33. Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA). Pengo V; Crippa L; Falanga A; Finazzi G; Marongiu F; Palareti G; Poli D; Testa S; Tiraferri E; Tosetto A; Tripodi A; Manotti C; Thromb Haemost; 2011 Nov; 106(5):868-76. PubMed ID: 21946939 [TBL] [Abstract][Full Text] [Related]
34. [New anticoagulants: "efficacy and safety" or "efficacy or safety"]. Pernod G J Mal Vasc; 2011 Dec; 36(6):337-8. PubMed ID: 21907510 [No Abstract] [Full Text] [Related]
35. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M; Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865 [TBL] [Abstract][Full Text] [Related]
39. The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War? Diener HC; Eikelboom J; Granger CB; Hacke W Int J Stroke; 2012 Feb; 7(2):139-41. PubMed ID: 22264366 [TBL] [Abstract][Full Text] [Related]
40. Insights from the dabigatran versus warfarin trial in patients with venous thromboembolism (the RE-COVER trial). Prandoni P; Taher A Expert Opin Pharmacother; 2010 Apr; 11(6):1035-7. PubMed ID: 20307227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]